Use of partial exchange transfusion preoperatively in patients with sickle cell hemoglobinopathies.
Sickle cell anemia and other severe sickle cell disorders (hemoglobin SC and hemoglobin S-thalassemia) are known to complicate surgical procedures in susceptible patients. Although transfusions have been used preoperatively to increase the packed cell volume, we have recently used the method of partial exchange transfusion in the treatment of patients with these disorders in the preoperative period. Forty-two patients with significant sickle cell hemoglobinopathies underwent operative procedures on various surgical services. The goal was to obtain a hemoglobin A percentage of 40 or above in each case, and this required 480 to 1,150 c.c. of buffy coat poor washed red cells (mean 820 c.c.). The number of complications in the intraoperative and postoperative period in this study was compared to those found in the literature. There was a significant decrease in morbidity and mortality rates noted with the use of these transfusions. There appeared to be a great advantage on a cost-benefit ratio, as well as an improvement in the physiologic state of the patient. Although the results of this study show significant improvement over previous investigations, there are many facets unknown concerning the use of this modality under these and other conditions. Therefore, further investigation of this method and restriction of the method of Level III referral centers is advocated until enough patients have been studied to assess the long- and short-term complications of the procedure.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell; D005078:Exchange Transfusion, Whole Blood / Q000009:adverse effects; D005260:Female; D006441:Hemoglobin A; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D013514:Surgical Procedures, Operative; D013789:Thalassemia; D013997:Time Factors
D006441:Hemoglobin A